documents: FDA-2013-N-0195-0100
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2013-N-0195-0100 | FDA | FDA-2013-N-0195 | Effective Date of Requirement for Premarket Approval for Transilluminator for Breast Evaluation and Sorbent Hemoperfusion System (SHS) Devices for the Treatment of Hepatic Coma and Metabolic Disturbances; Reclassification of SHS Devices for the Treatment of Poisoning and Drug Overdose | Rule | Final Rule | 2014-01-17T05:00:00Z | 2014 | 1 | 2014-01-17T05:00:00Z | 2014-01-17T15:57:55Z | 2014-00873 | 0 | 0 | 0900006481510c9a |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref